Ademetionine
CAS No. 17176-17-9
Ademetionine( —— )
Catalog No. M19348 CAS No. 17176-17-9
S-ADENOSYL-L-METHIONINE (SAM) is a ubiquitous methyl donor involved in a wide variety of biological reactions, including those mediated by DNA and protein methyltransferases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 38 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAdemetionine
-
NoteResearch use only, not for human use.
-
Brief DescriptionS-ADENOSYL-L-METHIONINE (SAM) is a ubiquitous methyl donor involved in a wide variety of biological reactions, including those mediated by DNA and protein methyltransferases.
-
DescriptionS-ADENOSYL-L-METHIONINE (SAM) is a ubiquitous methyl donor involved in a wide variety of biological reactions, including those mediated by DNA and protein methyltransferases. SAM reportedly ameliorates depression, pain associated with osteoarthritis and fibromyalgia, and liver toxicity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number17176-17-9
-
Formula Weight398.44
-
Molecular FormulaC15H22N6O5S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 250 mg/mL (627.45 mM)
-
SMILESC[S+](CCC(N)C([O-])=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N)ncnc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Loenen, W.A.M. S-Adenosylmethionine: Jack of all trades and master of everything? Biochemical Society Transactions 34(2), 330-333 (2006).
molnova catalog
related products
-
Uprosertib
Uprosertib (GSK2141795) is a selective, ATP-competitive, and orally bioavailable Akt inhibitor with IC50 of 180 nM, 328 nM, and 38 nM for Akt 1, 2 and 3, respectively. Phase 2.
-
Angiogenin 108-122
Angiogenin (108-122) is an angiogenin peptide. Angiogenin (108-122) acts as a therapeutic agent for the prophylaxis and/or treatment of cancer, an infectious disease, a fibrotic disease, an inflammatory disease, a neurodegenerative disease, an autoimmune disease, or a heart and vascular disease.
-
Pomalidomide-PEG3-OH
Pomalidomide-PEG3-OH enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology.